O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS

類似資料

• Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
  著者:: Onwordi, Ellis Chika, 等
  出版事項: (2020)
• The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
  著者:: Onwordi, Ellis Chika, 等
  出版事項: (2021)
• O5.5. THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: MULTI-MODAL PET AND FMRI FINDINGS
  著者:: Howes, Oliver, 等
  出版事項: (2020)
• Test–retest variability and reference region-based quantification of (18)F-BCPP-EF for imaging mitochondrial complex I in the human brain
  著者:: Mansur, Ayla, 等
  出版事項: (2020)
• 40.3 MATERNAL IMMUNE ACTIVATION AND CHRONIC HALOPERIDOL INTERACT TO INCREASE MICROGLIAL ACTIVATION IN VIVO: DO ANTIPSYCHOTICS INFLAME THE BRAIN?
  著者:: Cotel, Marie-Caroline, 等
  出版事項: (2018)